Hawaii Pacific Neuroscience is a clinical research site located in Honolulu, Hawaii, United States 96817.
Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.
Hawaii Pacific Neuroscience has participated in 59 clinical trials with 26 currently active.
Therapeutic areas: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Epilepsy, Chronic Migraine.
Sponsors: Takeda, Engage Therapeutics, Inc., Merz Therapeutics GmbH.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Hawaii · View every site in Honolulu
Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Hawaii Pacific Neuroscience has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hawaii Pacific Neuroscience has 59 clinical trials on record, with 26 currently active. Their work covers Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Epilepsy, Chronic Migraine.
Hawaii Pacific Neuroscience has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.